Interestingly, AZA treatment for 48 hours in MDS‐BMMSC and de novo AML‐BMMSC resulted in a pronounced up‐regulation of SPINT2 mRNA and HAI‐2 protein measured by qPCR and Western blot, respectively (Figure 1). Here, SPINT2 is linked to myelodysplastic syndrome.